Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7758881B2 · kind B2 · utility
14Cited by
467References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 24, 2005 |
| Grant date | Jul 20, 2010 |
| Priority date | — |
| Expiry date | Mar 24, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/606
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Drug-delivery systems such as drug-delivery stents having an anti-proliferative agent such as everolimus and an anti-inflammatory agent such as clobetasol are provided. Also disclosed are methods of treating a vascular impairment such as restenosis or vulnerable plaque
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.